Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Drug Design, Development and Therapy
|
February 14, 2023
Tebentafusp in the Treatment of Metastatic Uveal Melanoma: Patient Selection and Special Considerations
Kamaneh Montazeri, Vikram Pattanayak, Ryan J Sullivan
Methods in Enzymology
|
November 16, 2014
Determining the specificities of TALENs, Cas9, and other genome-editing enzymes
Vikram Pattanayak, John P Guilinger, David R Liu
RNA (New York, N.Y.)
|
March 25, 2008
Observed versus predicted structure of fluorescent self-quenching reporter molecules (SQRM): caveats with respect to the use of "stem-loop" oligonucleotides as probes for mRNA folding
Vikram Pattanayak, Lida K Gifford, Ponzy Lu, et al.
Nature Methods
|
August 9, 2011
Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection
Vikram Pattanayak, Cherie L Ramirez, J Keith Joung, et al.
The Journal of Investigative Dermatology
|
November 1, 2019
Association between Human Leukocyte Antigen Type and Keratinocyte Carcinoma Risk in Renal Transplant Recipients
Yuhree Kim, David Wojciechowski, Vikram Pattanayak, et al.
Journal of the American Chemical Society
|
February 16, 2006
Directed evolution and substrate specificity profile of homing endonuclease I-SceI
Jeffrey B Doyon, Vikram Pattanayak, Carissa B Meyer, et al.
Nature Chemical Biology
|
April 8, 2015
Small molecule-triggered Cas9 protein with improved genome-editing specificity
Kevin M Davis, Vikram Pattanayak, David B Thompson, et al.
Nature Biotechnology
|
August 13, 2013
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
Vikram Pattanayak, Steven Lin, John P Guilinger, et al.
Analytical Biochemistry
|
October 26, 2005
Stemless self-quenching reporter molecules identify target sequences in mRNA
Lida K Gifford, David Jordan, Vikram Pattanayak, et al.
Nature
|
January 7, 2016
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P Kleinstiver, Vikram Pattanayak, Michelle S Prew, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Drug Design, Development and Therapy
|
February 14, 2023
Tebentafusp in the Treatment of Metastatic Uveal Melanoma: Patient Selection and Special Considerations
Kamaneh Montazeri, Vikram Pattanayak, Ryan J Sullivan
Methods in Enzymology
|
November 16, 2014
Determining the specificities of TALENs, Cas9, and other genome-editing enzymes
Vikram Pattanayak, John P Guilinger, David R Liu
RNA (New York, N.Y.)
|
March 25, 2008
Observed versus predicted structure of fluorescent self-quenching reporter molecules (SQRM): caveats with respect to the use of "stem-loop" oligonucleotides as probes for mRNA folding
Vikram Pattanayak, Lida K Gifford, Ponzy Lu, et al.
Nature Methods
|
August 9, 2011
Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection
Vikram Pattanayak, Cherie L Ramirez, J Keith Joung, et al.
The Journal of Investigative Dermatology
|
November 1, 2019
Association between Human Leukocyte Antigen Type and Keratinocyte Carcinoma Risk in Renal Transplant Recipients
Yuhree Kim, David Wojciechowski, Vikram Pattanayak, et al.
Journal of the American Chemical Society
|
February 16, 2006
Directed evolution and substrate specificity profile of homing endonuclease I-SceI
Jeffrey B Doyon, Vikram Pattanayak, Carissa B Meyer, et al.
Nature Chemical Biology
|
April 8, 2015
Small molecule-triggered Cas9 protein with improved genome-editing specificity
Kevin M Davis, Vikram Pattanayak, David B Thompson, et al.
Nature Biotechnology
|
August 13, 2013
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
Vikram Pattanayak, Steven Lin, John P Guilinger, et al.
Analytical Biochemistry
|
October 26, 2005
Stemless self-quenching reporter molecules identify target sequences in mRNA
Lida K Gifford, David Jordan, Vikram Pattanayak, et al.
Nature
|
January 7, 2016
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P Kleinstiver, Vikram Pattanayak, Michelle S Prew, et al.
Page
of 3